Data analysis in flow cytometry: The future just started

Authors

  • Enrico Lugli,

    Corresponding author
    1. Immuno Technology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892
    • ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, 40, Convent Drive, 20892, Bethesda, MD, USA
    Search for more papers by this author
  • Mario Roederer,

    1. Immuno Technology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892
    Search for more papers by this author
  • Andrea Cossarizza

    Corresponding author
    1. Department of Biomedical Sciences, University of Modena and Reggio Emilia, via Campi 287, 41125, Modena, Italy
    • Department of Biomedical Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125, Modena, Italy
    Search for more papers by this author

  • This article is a US government work and, as such, is in the public domain in the United States of America.

Abstract

In the last 10 years, a tremendous progress characterized flow cytometry in its different aspects. In particular, major advances have been conducted regarding the hardware/instrumentation and reagent development, thus allowing fine cell analysis up to 20 parameters. As a result, this technology generates very complex datasets that demand for the development of optimal tools of analysis. Recently, many independent research groups approached the problem by using both supervised and unsupervised methods. In this article, we will review the new developments concerning the use of bioinformatics for polychromatic flow cytometry and propose what should be done to unravel the enormous heterogeneity of the cells we interrogate each day. Published 2010 Wiley-Liss,Inc.

Ancillary